{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:25:41Z","timestamp":1789097141036,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":1173,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1111\/ajt.15515","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T13:03:22Z","timestamp":1561640602000},"page":"2479-2494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Cytomegalovirus (CMV) infection and risk of mortality in allogeneic hematopoietic stem cell transplantation (Allo-HSCT): A systematic review, meta-analysis, and meta-regression analysis"],"prefix":"10.1016","volume":"19","author":[{"given":"Estela","family":"Gim\u00e9nez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliseo","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Luis","family":"Pi\u00f1ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Carlos","family":"Hern\u00e1ndez-Boluda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Solano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3010-4110","authenticated-orcid":false,"given":"David","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1111\/ajt.15515_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2217\/fvl.14.102","article-title":"An update on the management and prevention of cytomegalovirus infection following allogeneic hematopoietic stem cell transplantation","volume":"10","author":"P\u00e9rez-Romero","year":"2015","journal-title":"Future Virol."},{"issue":"19","key":"10.1111\/ajt.15515_bib2","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1309533","article-title":"Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation","volume":"370","author":"Chemaly","year":"2014","journal-title":"N Engl J Med."},{"issue":"25","key":"10.1111\/ajt.15515_bib3","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1111\/ajt.15515_bib4","doi-asserted-by":"crossref","unstructured":"Green ML, Leisenring WM, Xie H, et al. CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. Blood. 2013; https:\/\/doi.org\/10.1182\/blood-2013-2002-487074.","DOI":"10.1182\/blood-2013-02-487074"},{"issue":"12","key":"10.1111\/ajt.15515_bib5","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.bbmt.2014.08.010","article-title":"Cytomegalovirus infection in patients who underwent allogeneic hematopoietic stem cell transplantation in Portugal: a five-year retrospective review","volume":"20","author":"Sousa","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"issue":"6","key":"10.1111\/ajt.15515_bib6","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbmt.2014.02.015","article-title":"Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantation","volume":"20","author":"Mariotti","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"issue":"11","key":"10.1111\/ajt.15515_bib7","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.bbmt.2015.07.019","volume":"21","author":"Takenaka","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"issue":"3","key":"10.1111\/ajt.15515_bib8","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/S2352-3026(15)00289-6","article-title":"CMV viral load and mortality after hematopoietic cell transplantation: a cohort study in the era of preemptive therapy","volume":"3","author":"Green","year":"2016","journal-title":"Lancet Haematol."},{"issue":"3","key":"10.1111\/ajt.15515_bib9","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/cid\/cix804","article-title":"Kinetics of double-stranded DNA viremia after allogeneic hematopoietic cell Transplantation","volume":"66","author":"Hill","year":"2017","journal-title":"Clin Infect Dis."},{"key":"10.1111\/ajt.15515_bib10","doi-asserted-by":"crossref","unstructured":"Gim\u00e9nez E, Solano C, Vinuesa V, et al. Cytomegalovirus DNAemia burden and mortality following allogeneic hematopoietic stem cell transplantation: an area under a curve-based investigational approach. Clin Infect Dis. 2018.","DOI":"10.1093\/cid\/ciy138"},{"key":"10.1111\/ajt.15515_bib11","doi-asserted-by":"crossref","unstructured":"Webb BJ, Harrington R, Schwartz J, et al. Clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation. Transpl Infect Dis. 2018;e12961.","DOI":"10.1111\/tid.12961"},{"issue":"4","key":"10.1111\/ajt.15515_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12717","article-title":"Impact of cytomegalovirus DNAemia on overall and nonrelapse mortality in allogeneic stem cell transplant recipients","volume":"19","author":"Solano","year":"2017","journal-title":"Transpl Infect Dis."},{"issue":"12","key":"10.1111\/ajt.15515_bib13","doi-asserted-by":"crossref","first-page":"1121.e9","DOI":"10.1016\/j.cmi.2015.06.009","article-title":"Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and nonrelapse mortality","volume":"21","author":"Liu","year":"2015","journal-title":"Clin Microbiol Infect."},{"issue":"11","key":"10.1111\/ajt.15515_bib14","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.3324\/haematol.2016.149880","article-title":"Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide","volume":"101","author":"Goldsmith","year":"2016","journal-title":"Haematologica."},{"issue":"4","key":"10.1111\/ajt.15515_bib15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med."},{"issue":"1","key":"10.1111\/ajt.15515_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials."},{"key":"10.1111\/ajt.15515_bib17","unstructured":"Wells G, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. 2015. In., 2016."},{"key":"10.1111\/ajt.15515_bib18","series-title":"R: A language and environment for statistical computing","year":"2014"},{"issue":"3","key":"10.1111\/ajt.15515_bib19","first-page":"40","article-title":"meta: An R package for meta-analysis","volume":"7","author":"Schwarzer","year":"2007","journal-title":"R News."},{"issue":"3","key":"10.1111\/ajt.15515_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw."},{"issue":"1","key":"10.1111\/ajt.15515_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/01.tp.0000190102.15300.7d","article-title":"Survival benefit of asymptomatic cytomegalovirus reactivation after HLA-identical allogeneic peripheral blood stem cell transplantation","volume":"81","author":"Kim","year":"2006","journal-title":"Transplantation."},{"issue":"12","key":"10.1111\/ajt.15515_bib22","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/tri.12406","article-title":"Timing of CMV-specific effector memory T cells predicts viral replication and survival after allogeneic hematopoietic stem cell transplantation","volume":"27","author":"Espigado","year":"2014","journal-title":"Transpl Int."},{"issue":"1","key":"10.1111\/ajt.15515_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbmt.2013.10.003","article-title":"Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen","volume":"20","author":"Manjappa","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"issue":"10","key":"10.1111\/ajt.15515_bib24","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.bbmt.2016.07.009","article-title":"Cytomegalovirus status and the outcome of T cell\u2013replete reduced-intensity allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Lunel","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"issue":"13","key":"10.1111\/ajt.15515_bib25","doi-asserted-by":"crossref","first-page":"17230","DOI":"10.18632\/oncotarget.7347","article-title":"Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission","volume":"7","author":"Yoon","year":"2016","journal-title":"Oncotarget."},{"key":"10.1111\/ajt.15515_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.leukres.2017.02.009","article-title":"Cytomegalovirus reactivation is associated with a lower rate of early relapse in myeloid malignancies independent of in-vivo T cell depletion strategy","volume":"57","author":"Hilal","year":"2017","journal-title":"Leuk Res."},{"issue":"2","key":"10.1111\/ajt.15515_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4274\/tjh.2016.0225","article-title":"Cytomegalovirus infection and treatment in allogeneic hematopoietic stem cell transplantation: a retrospective study from a single institution in an endemic area","volume":"34","author":"Lin","year":"2017","journal-title":"Turk J Hematol."},{"issue":"4","key":"10.1111\/ajt.15515_bib28","doi-asserted-by":"crossref","first-page":"e12717","DOI":"10.1111\/tid.12717","article-title":"Impact of cytomegalovirus DNA emia on overall and nonrelapse mortality in allogeneic stem cell transplant recipients","volume":"19","author":"Solano","year":"2017","journal-title":"Transpl Infect Dis."},{"issue":"3","key":"10.1111\/ajt.15515_bib29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1086\/514569","article-title":"Effect of cytomegalovirus infection on 1-year mortality rates among recipients of allogeneic bone marrow transplants","volume":"26","author":"Humar","year":"1998","journal-title":"Clin Infect Dis."},{"issue":"4","key":"10.1111\/ajt.15515_bib30","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1046\/j.1365-2141.2001.02849.x","volume":"113","author":"Kr\u00f6ger","year":"2001","journal-title":"Br J Haematol."},{"issue":"2","key":"10.1111\/ajt.15515_bib31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","article-title":"Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity","volume":"101","author":"Boeckh","year":"2003","journal-title":"Blood."},{"issue":"8","key":"10.1111\/ajt.15515_bib32","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/sj.bmt.1704232","article-title":"Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"32","author":"Yanada","year":"2003","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1111\/ajt.15515_bib33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12185-008-0051-1","article-title":"Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantation","volume":"87","author":"Asano-Mori","year":"2008","journal-title":"Int J Hematol."},{"issue":"5","key":"10.1111\/ajt.15515_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1399-3062.2008.00325.x","article-title":"Use of the cytomegalovirus pp65 antigenemia assay for preemptive therapy in allogeneic hematopoietic stem cell transplantation: a real-world review","volume":"10","author":"Tan","year":"2008","journal-title":"Transpl Infect Dis."},{"issue":"2","key":"10.1111\/ajt.15515_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbmt.2009.09.019","article-title":"Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation","volume":"16","author":"Beck","year":"2010","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1111\/ajt.15515_bib36","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","article-title":"Early cytomegalovirus reactivation remains associated with increased transplant related mortality in the current era: a CIBMTR analysis","volume":"127","author":"Teira","year":"2016","journal-title":"Blood."},{"issue":"5","key":"10.1111\/ajt.15515_bib37","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood-2010-08-304121","article-title":"Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients","volume":"118","author":"Elmaagacli","year":"2011","journal-title":"Blood."},{"key":"10.1111\/ajt.15515_bib38","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1182\/blood-2011-09-381699","article-title":"Outcomes after matched unrelated donor vs. identical sibling hematopoietic cell transplantation (HCT) in adults with acute myelogenous leukemia (AML)","volume":"119","author":"Saber","year":"2012","journal-title":"Blood."},{"issue":"11","key":"10.1111\/ajt.15515_bib39","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.bbmt.2014.06.011","article-title":"Unrelated cord blood transplantation for patients with primary or secondary myelofibrosis","volume":"20","author":"Robin","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1111\/ajt.15515_bib40","unstructured":"Kollman C, Spellman SR, Zhang M-J, et al. The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. Blood. 2015. https:\/\/doi.org\/10.1182\/blood-2015-2008-663823."},{"issue":"22","key":"10.1111\/ajt.15515_bib41","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1056\/NEJMoa041469","article-title":"Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia","volume":"351","author":"Rocha","year":"2004","journal-title":"N Engl J Med."},{"issue":"10","key":"10.1111\/ajt.15515_bib42","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.bbmt.2011.02.001","article-title":"Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin","volume":"17","author":"Sauter","year":"2011","journal-title":"Biol Blood Marrow Transplant."},{"issue":"4","key":"10.1111\/ajt.15515_bib43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbmt.2014.01.001","article-title":"Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation","volume":"20","author":"Servais","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1111\/ajt.15515_bib44","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/cid\/ciy139","article-title":"Reply to Gim\u00e9nez et al.","volume":"16","author":"Hill","year":"2018","journal-title":"Clin Infect Dis."},{"issue":"1","key":"10.1111\/ajt.15515_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M13-2729","article-title":"Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial","volume":"162","author":"Boeckh","year":"2015","journal-title":"Ann Intern Med."},{"issue":"7","key":"10.1111\/ajt.15515_bib46","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bbmt.2007.03.009","article-title":"Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis","volume":"13","author":"Battiwalla","year":"2007","journal-title":"Biol Blood Marrow Transplant."},{"issue":"6","key":"10.1111\/ajt.15515_bib47","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1182\/blood.V90.6.2502","article-title":"Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome","volume":"90","author":"Salzberger","year":"1997","journal-title":"Blood."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15515","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15515","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15515","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522092231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522092231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15515","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:24:05Z","timestamp":1761629045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522092231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1600613522092231"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15515","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytomegalovirus (CMV) infection and risk of mortality in allogeneic hematopoietic stem cell transplantation (Allo-HSCT): A systematic review, meta-analysis, and meta-regression analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}